Education
About Us
Working with TipRanks
Follow Us
Addus Homecare (ADUS)
NASDAQ:ADUS
ADUS Stock Chart & Stats
$103.71
-$0.15(-0.12%)
At close: 4:00 PM EST
$103.71
-$0.15(-0.12%)
Day’s Range― - ―
52-Week Range$88.96 - $124.44
Previous CloseN/A
Volume20.85K
Average Volume (3M)172.76K
Market Cap
$1.96B
Enterprise Value$2.02B
Total Cash (Recent Filing)$101.92M
Total Debt (Recent Filing)$202.49M
Price to Earnings (P/E)22.2
Beta0.45
Next Earnings
Feb 23, 2026EPS Estimate
1.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.56
Shares Outstanding18,483,270
10 Day Avg. Volume149,463
30 Day Avg. Volume172,765
Financial Highlights & Ratios
PEG Ratio2.70
Price to Book (P/B)2.20
Price to Sales (P/S)1.85
P/FCF Ratio19.31
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue1.50
Enterprise Value/Gross Profit4.59
Enterprise Value/Ebitda14.27
Forecast
1Y Price Target
$135.25Price Target Upside30.41% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Organic Revenue Growth TargetManagement's expectation of mid-to-upper single-digit organic revenue growth underpins top-line momentum and raises investor confidence in sustainable demand.
State Reimbursement IncreaseA 10% Medicaid rate increase in Texas enhances revenue potential in the state and supports local margin expansion for in-home care operations.
Technology And Clinical Service ExpansionRollout of a new caregiver app, EHR enhancements, and efforts to layer clinical services into personal-care offerings could improve service delivery, patient retention, and operational efficiency.
Bears Say
Clawback OverhangA $4.7 billion clawback in the home health sector remains an overhang, constraining cash-flow expectations and pressuring valuation multiples for providers concentrated in affected markets.
Medicaid Reform UncertaintyOngoing uncertainty around Medicaid reform and the impending Medicaid Access Rule remains a valuation overhang that could complicate reimbursement predictability and investor sentiment.
Medicare Payment Reduction RiskThe final Medicare rule is expected to reduce payments to home health agencies by about $220 million in 2026, creating revenue and margin headwinds and highlighting exposure to regulatory adjustments.
Addus Homecare News
ADUS FAQ
What was Addus Homecare’s price range in the past 12 months?
Addus Homecare lowest stock price was $88.96 and its highest was $124.44 in the past 12 months.
What is Addus Homecare’s market cap?
Addus Homecare’s market cap is $1.96B.
When is Addus Homecare’s upcoming earnings report date?
Addus Homecare’s upcoming earnings report date is Feb 23, 2026 which is in 12 days.
How were Addus Homecare’s earnings last quarter?
Addus Homecare released its earnings results on Nov 03, 2025. The company reported $1.56 earnings per share for the quarter, beating the consensus estimate of $1.534 by $0.026.
Is Addus Homecare overvalued?
According to Wall Street analysts Addus Homecare’s price is currently Undervalued.
Does Addus Homecare pay dividends?
Addus Homecare does not currently pay dividends.
What is Addus Homecare’s EPS estimate?
Addus Homecare’s EPS estimate is 1.72.
How many shares outstanding does Addus Homecare have?
Addus Homecare has 18,483,270 shares outstanding.
What happened to Addus Homecare’s price movement after its last earnings report?
Addus Homecare reported an EPS of $1.56 in its last earnings report, beating expectations of $1.534. Following the earnings report the stock price went down -5.69%.
Which hedge fund is a major shareholder of Addus Homecare?
Currently, no hedge funds are holding shares in ADUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Addus Homecare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$135.25 (30.41% Upside)
$135.25 (30.41% Upside)
Hedge Fund Trend
Decreased
By 2.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $2.2M over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.13%
12-Months-Change
Fundamentals
Return on Equity
8.58%
Trailing 12-Months
Asset Growth
23.42%
Trailing 12-Months
Company Description
Addus Homecare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. As of December 31, 2021, the company served consumers through 206 offices located in 22 states. Addus HomeCare Corporation was founded in 1979 and is based in Frisco, Texas.
ADUS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call displayed strong revenue growth and successful expansion through acquisitions, particularly in the personal care segment. However, there are challenges in the home health sector due to potential Medicare payment cuts and hiring difficulties in urban areas. The positive momentum in personal care and strategic acquisitions indicate future growth potential.View all ADUS earnings summariesADUS Stock 12 Month Forecast
Average Price Target
$135.25
▲(30.41% Upside)
Technical Analysis
National Healthcare
―
Select Medical
―
US Physical Therapy
―
Pennant Group
―
Aveanna Healthcare Holdings
―
Ownership Overview
Currently, No data available
---